Vasomotor Symptoms of Menopause Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Vasomotor Symptoms of Menopause Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Amgen Inc.
EndoCeutics, Inc.
Euroscreen S.A.
MenoGeniX, Inc.
Mithra Pharmaceuticals S.A.
Pherin Pharmaceuticals, Inc.
Pivot Pharmaceuticals Inc
Radius Health, Inc.
TherapeuticsMD, Inc.

Market segment by Type, the product can be split into
Estetrol
Fezolinetant
FP-101
HBN-2
Others
Market segment by Application, split into
Hospital
Homecare
Clinic

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America